Ovid Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
And good morning, everyone. Thank you for joining us. This is Michael Higgins. I'm managing director and senior biotech analyst here at Ladenburg Thalmann. Welcome to our healthcare conference or virtual healthcare conference. Very pleased to introduce the Cofounder and CEO of Ovid Therapeutics, Dr. Jeremy Levin, to go through his Company's slide deck. We'll have a little time at the end there for Q&A as well. Look forward to that. Jeremy, I will jump out of the way and let you run through the slides. Thank you for participating with our conference.
Thank you, Michael. And Michael, I will just take a few slides. This is Ovid 2.0. So I want to really level set everybody and show them where we are going and give an opportunity for you and I to have a really robust discussion at the end. So obviously a public company, clearly this is the forward-looking statement. And for investors who are watching today, let me just tell you what we are going to be doing.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
